tradmap

SCNX Financials Scienture Holdings, Inc.

13 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has declined 52.1% per year over the past 5 years.
  • Operating margin has contracted, at -9867.9% in the latest year.

Financial health

  • Total debt has grown faster than revenue (66.7% vs -52.1% per year).
  • Operating income covered interest expense -10.4× in the latest year.
Revenue & net income
-$42M -$12M $17M $0 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-10759% -2062% 6635% 0% 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-3290% -1525% 240% 0% 2013 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
-$14M -$7M $0 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $3M $7M 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$14M $7M $28M $0 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $431609 -$42M 76.8% -9867.9% -59.2% -49.3% $7M
2024 $136643 $9M 4.4% -10758.7% 11.5% 8.6% -$14M $3M $308096
2023 $1M -$18M 3.6% -322.4% -3290.0% -142.4% $361
2022 $10M -$3M 53.8% -28.4% -455.0% -93.6% $1M
2021 $10M -$5M 48.0% -53.5% -141.0% -92.2% -$3M $3M
2020 $17M -$3M 33.3% -14.6% -29.2% -25.9% -$2M $6M
2019 $7M -$284428 65.5% 1.7% -6.9% -5.1% $225000 $3M
2018 $4M $9038 88.3% -2.3% 1.1% 0.4% $522052 $869557
2017 $288983 -92.6% 46.8% $666516 $183914
2016 -$3M 240.4% -818.7% $14679
2015 -$1M -418.4% -55.1% $78708
2014 -$2M -301.0% -164.6% $695817
2013 -$2M -1598.0% -517.8% -$855568 $84317

Valuation over time

How the market has priced SCNX against its own fundamentals since 2024-09 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 13.7 27.5 Sep '24 Jan '25 May '25 Sep '25 Jan '26 May '26 Sep '26
P/E
Price / sales (P/S)
0.0 912.1 1824.2 Sep '24 Jan '25 May '25 Sep '25 Jan '26 May '26 Sep '26
P/S
Dividend yield (%)
0.0 30.4 60.8 Sep '24 Jan '25 May '25 Sep '25 Jan '26 May '26 Sep '26
Dividend yield %

Frequently asked questions

Is SCNX growing its revenue and profit?

Over the past 5 years, Scienture Holdings, Inc.'s revenue has declined 52.1% per year. These are computed facts, not advice.

How much debt does SCNX have?

As of FY2025, Scienture Holdings, Inc. reported — of total debt against $7M of cash; operating income covered interest expense -10.4×.

What is SCNX's profit margin?

In FY2025, gross margin was 76.8%, operating margin -9867.9%, and net margin -9618.0%.

What is SCNX's P/E ratio?

As of Sep '26, Scienture Holdings, Inc. traded at a price-to-earnings ratio of about 2.7× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.